Company Filing History:
Years Active: 2002
Title: Torben Lund: Innovator in Medical Proteins
Introduction
Torben Lund is a notable inventor based in London, GB. He has made significant contributions to the field of medical science, particularly through his innovative work on modified human chorionic gonadotropin proteins.
Latest Patents
Lund holds a patent for "Modified human chorionic gonadotropin (β-hCG) proteins and their medical use." This invention relates to the development of modified β-hCG proteins that serve as immunological contragestatives. The modification is designed to reduce the cross-reactivity of the modified β-hCG protein with luteinizing hormone (LH), as defined by the ability of both proteins to react with the same antibody. He has 1 patent to his name.
Career Highlights
Torben Lund is affiliated with University College London, where he continues to advance research in his field. His work has implications for medical treatments and therapies, showcasing his commitment to innovation in healthcare.
Collaborations
Lund has collaborated with esteemed colleagues such as Ivan Maurice Roitt and Peter John Delves. Their combined expertise has contributed to the advancement of research in immunology and medical applications.
Conclusion
Torben Lund's innovative work in the field of modified human chorionic gonadotropin proteins highlights his significant contributions to medical science. His research continues to pave the way for advancements in immunological treatments.